Iain Alasdair Keith Moodie
Amministratore Delegato presso Inel SAS
Profilo
Iain Alasdair Keith Moodie is currently the Co-Chief Executive Officer at Inel SAS, Director at Oxoid International Ltd., and Trustee at UK DRI Ltd.
He was formerly the Chairman at Cezanne SAS and Managing Director at B·R·A·H·M·S GmbH.
Posizioni attive di Iain Alasdair Keith Moodie
Società | Posizione | Inizio |
---|---|---|
Inel SAS
Inel SAS Medical SpecialtiesHealth Technology Inel SAS designs and manufactures x-ray diffraction system. It offers its solution for research and routine analytical applications. Its products are sold under the brand names of EQUINOX 100, EQUINOX 5000, SWAXS System, Nomadic stress system and Xsolo. The company was founded in 1974 by Michel Hugnot and is headquartered in Artenay, France. | Amministratore Delegato | - |
Oxoid International Ltd.
Oxoid International Ltd. Medical DistributorsDistribution Services Part of Thermo Fisher Scientific, Inc., Oxoid International Ltd. is a holding British company that offers diagnostic products to microbiology laboratories. The company is based in Altrincham, UK. | Direttore/Membro del Consiglio | - |
UK DRI Ltd.
UK DRI Ltd. BiotechnologyHealth Technology UK DRI Ltd. is a national institute that specializes in biomedical, care, and translational dementia research. The joint venture company is based in London, UK. The British company breaks new ground by bringing together world-leading expertise in these fields. | Direttore/Membro del Consiglio | - |
Precedenti posizioni note di Iain Alasdair Keith Moodie
Società | Posizione | Fine |
---|---|---|
Cezanne SAS
Cezanne SAS Pharmaceuticals: MajorHealth Technology Cezanne SAS develops and manufactures medical diagnostic systems, instrumentation, and reagents. The company was founded on June 23, 2000 and is headquartered in Nimes, France. | Presidente | - |
B·R·A·H·M·S GmbH
B·R·A·H·M·S GmbH Miscellaneous Commercial ServicesCommercial Services B·R·A·H·M·S GmbH engages in the development and manufacture of novel diagnostic testing procedures. Its products include B·R·A·H·M·S PCT (Procalcitonin), MR-proADM (Mid-regional proadrenomedullin), Copeptin proAVP, Neopterin, and KRYPTOR Instruments. The company was founded in 1994 and is headquartered in Hennigsdorf, Germany. | Corporate Officer/Principal | - |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Aziende private | 5 |
---|---|
B·R·A·H·M·S GmbH
B·R·A·H·M·S GmbH Miscellaneous Commercial ServicesCommercial Services B·R·A·H·M·S GmbH engages in the development and manufacture of novel diagnostic testing procedures. Its products include B·R·A·H·M·S PCT (Procalcitonin), MR-proADM (Mid-regional proadrenomedullin), Copeptin proAVP, Neopterin, and KRYPTOR Instruments. The company was founded in 1994 and is headquartered in Hennigsdorf, Germany. | Commercial Services |
Cezanne SAS
Cezanne SAS Pharmaceuticals: MajorHealth Technology Cezanne SAS develops and manufactures medical diagnostic systems, instrumentation, and reagents. The company was founded on June 23, 2000 and is headquartered in Nimes, France. | Health Technology |
Inel SAS
Inel SAS Medical SpecialtiesHealth Technology Inel SAS designs and manufactures x-ray diffraction system. It offers its solution for research and routine analytical applications. Its products are sold under the brand names of EQUINOX 100, EQUINOX 5000, SWAXS System, Nomadic stress system and Xsolo. The company was founded in 1974 by Michel Hugnot and is headquartered in Artenay, France. | Health Technology |
Oxoid International Ltd.
Oxoid International Ltd. Medical DistributorsDistribution Services Part of Thermo Fisher Scientific, Inc., Oxoid International Ltd. is a holding British company that offers diagnostic products to microbiology laboratories. The company is based in Altrincham, UK. | Distribution Services |
UK DRI Ltd.
UK DRI Ltd. BiotechnologyHealth Technology UK DRI Ltd. is a national institute that specializes in biomedical, care, and translational dementia research. The joint venture company is based in London, UK. The British company breaks new ground by bringing together world-leading expertise in these fields. | Health Technology |
- Borsa valori
- Insiders
- Iain Alasdair Keith Moodie